Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02460718
Other study ID # T0808270039
Secondary ID
Status Completed
Phase N/A
First received May 29, 2015
Last updated March 9, 2016
Start date February 2009
Est. completion date February 2012

Study information

Verified date March 2016
Source Weill Medical College of Cornell University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

It is unclear whether peer coaching is effective in minority populations living with diabetes in hard-to-reach, under resourced areas such as the rural South. We examined the effect of an innovative peer coaching intervention plus brief education vs. brief education alone on diabetes outcomes.


Description:

The purpose of this project was to provide robust evidence on the effectiveness of a peer support intervention in improving diabetes outcomes by conducting a group-randomized, controlled implementation trial of a volunteer peer support intervention.

The study had three specific aims:

Aim 1. In Phase I (months 0-8), to perform a qualitative needs assessment with peer advisors and health care providers to inform peer advisor roles and responsibilities (i.e., the intervention) and peer advisor recruitment strategies, curriculum and training; and patient recruitment plans.

Aim 2. Also in Phase I, to pilot our collaboratively developed intervention and, based on pilot test results, to recruit and train peer advisors for the intervention, and begin patient recruitment.

Aim 3. In Phase II (months 9-32), conduct the group randomized implementation trial and evaluate it using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.


Recruitment information / eligibility

Status Completed
Enrollment 424
Est. completion date February 2012
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria:

- 19 or older in age, diagnosed with diabetes, under the care of a doctor

Exclusion Criteria:

- not community dwelling, less than 19 years old, pregnant, end-stage medical conditions with limited life expectancy, no access to telephone, does not speak english

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
ENCOURAGE Study
This intervention tested the effects of a peer coaching program plus brief diabetes education versus brief diabetes education alone on diabetes outcomes.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Weill Medical College of Cornell University University of Alabama at Birmingham

Outcome

Type Measure Description Time frame Safety issue
Primary Glycated hemoglobin (A1c) fingerstick, point-of-care a1c test Change in A1c in 12 months No
Primary Blood pressure Measured using digital automated blood pressure monitor Change in blood pressure measure in 12 months No
Primary LDL cholesterol measured using finger stick, spectrophotometer to measure LDL cholesterol Change in LDL cholesterol in 12 month No
Primary diabetes self-care behaviors questionnaire aspects of diabetes self-management such as taking medications as directed, self-report of exercise, and eating behaviors Change in diabetes self-care behaviors at 12 months No
Primary depressive symptoms self-report using Patient Health Questionnaire 8 (PHQ8) change in depressive symptoms at 12 months No
Primary quality of life self-report using Short form-1 (SF1), and Euroquol (EQ-5D) Change in quality of life measures at 12 months No
Primary patient activation self-report using the 13 item Patient Activation Measure (PAM13) change in patient activation in 12 months No
Secondary body mass index weight measured using digital scale, height measured using stadiometer change in BMI in 12 months No
Secondary diabetes knowledge assessed using the Spoken Knowledge in Low Literacy in Diabetes Scale change in diabetes knowledge in 12 months No
Secondary trust in physicians assessed using the Trust in Physicians Scale change in trust in physicians in 12 months No
Secondary composite measure of healthcare utilization self-report by participant, number of times utilized healthcare services Change in health care utilization in 12 months No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A